If you’ve been exploring advanced treatments for dry eye or ocular surface disease, you’ve probably come across two alphabet-soup options: PRP and PRGF eye drops. They sound similar—and they are related (like cousins)—but they are not exactly the same.
Both are biologic eye drops made from your own blood and designed to help heal the ocular surface. Think of them as regenerative medicine for your eyes: instead of simply lubricating the surface like artificial tears, they deliver growth factors and proteins that actively support tissue repair.
Both Platelet-Rich Plasma (PRP) and Plasma Rich in Growth Factors (PRGF) are forms of autologous blood therapy, meaning the drops are created from your own blood sample.
The process is similar for both:

PRP, or Platelet-Rich Plasma, is generally the more traditional and widely available option.
It is made by concentrating platelets within plasma. Platelets release growth factors that promote tissue healing and regeneration. Depending on how PRP is prepared, the final product may also contain white blood cells and inflammatory cytokines.
A good way to think about PRP is as a powerful but less controlled formulation: effective for many patients, but somewhat dependent on how it is prepared.

PRGF, or Plasma Rich in Growth Factors, is a more standardized and processed form of PRP originally developed by the BTI Biotechnology Institute using the Endoret® system.
The major difference is that PRGF is specifically designed to remove leukocytes (white blood cells) and inflammatory components while preserving concentrated growth factors.
PRGF undergoes additional processing steps:
This creates a cleaner and more predictable product.
In simple terms:
Studies show that both PRP and PRGF can significantly improve:
Both therapies are particularly helpful in moderate-to-severe dry eyes that have not responded well to conventional artificial tears.
Research sometimes suggests PRGF may provide:
After LASIK or other corneal procedures, patients often experience dryness, burning, and delayed epithelial recovery.
PRP has been shown to:
PRGF may offer additional benefits:
Both PRP and PRGF are used clinically for difficult corneal wounds and persistent epithelial defects.
PRGF may have an advantage in severe ocular surface disease because:
Both PRP and PRGF generally have excellent safety profiles because they are autologous products derived from the patient’s own blood. The risk of rejection is therefore extremely low.
However, preparation quality matters. These drops are typically compounded in specialized laboratories or ophthalmology clinics under physician supervision.
Neither PRP nor PRGF eye drops are currently FDA-approved as mass-produced commercial products.
PRGF:
PRP:
It’s like picking who your favorite child might be – there is no universal winner.
A simple comparison:
Regenerative eye drops are one of the more exciting developments in ocular surface disease treatment. They move beyond symptom management and actually promote healing.
PRP opened the door. PRGF is refining the experience.
Both work best as part of a broader dry eye management plan that may also include:
Neither is magic—but for many patients, they come pretty close.
By: Jean Mengoli, OD
If your eyes are constantly itchy, red, irritated, crusty, or dry — and artificial tears...
Read MoreIf you've been struggling with chronic dry eyes, irritated eyelids, crusting along the lash line,recurrent...
Read MoreIf you’ve been exploring advanced treatments for dry eye or ocular surface disease, you’ve probably...
Read More